Endorepellin [77] acts through the dual engagement of α2β1 and VEGFR2, causing rapid internalization and downregulation of both receptors, a mechanism referred to as dual receptor antagonism [170,171], ultimately leading to transcriptional repression of HIF-1α and VEGFA, and anti-tumor effects [172,173,174]. Here, VEGFA is linked to neoplasm.